Great growth stocks can be tough to find, but our Motley Fool contributors have found five companies across different sectors of the market that they believe are second to none.
Which of these two big pharma dividend stocks is the better choice for long-term investors?
The streaming pioneer continues to invest heavily in improving its service, in order to capitalize on its humongous long-term market opportunity.
Motley Fool analyst John Rotonti sits down with Michael Mauboussin, investor, author, theorist, and professor.
These top potash stocks are so cheap today, they could fetch you great returns in the long run.